cardiovascular risk – Page 6 – Communicable Diseases Research

Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19

Cardiovascular Medicine

Published on 2021-04-232022-10-31
Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19,

[키워드] ACE2 acute respiratory syndrome anti-cancer drug-induced cardiac injury arrhythmia bone marrow cells Cancer cancer patient cardiovascular cardiovascular complication cardiovascular diseases cardiovascular risk clinically clinician Comorbidity coronavirus coronavirus disease COVID-19 COVID-19 patient Critical Cytokine storm damaged Diseases Effects Fatality rate global pandemic Health health emergency heart failure help highlight identification Immunocompromised IMPROVE Increased Infarction Infection Injury investigation knowledge mechanism myocardial injury Novel coronavirus outbreak outcome overlapping pathway Patient patients Prevalence Prognosis reported Respiratory disease risk SARS-CoV-2 shown spread of COVID-19 survivor Symptom therapy treated Treatment treatment regimen vascular disease vessels WHO with COVID-19 World Health Organization
[DOI] 10.3389/fcvm.2021.634291 PMC 바로가기 [Article Type] Cardiovascular Medicine

A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs

잠재적인 항-COVID-19 약물의 양날의 검-심혈관 문제

Review

Published on 2021-04-012022-09-11
Journal: Cardiovascular Drugs and Therapy [Category] SARS, 치료제,

[키워드] activating acute respiratory syndrome coronavirus addition Affect anti-SARS-CoV-2 Antiviral candidate drug cardiac conduction Cardiotoxicity cardiovascular risk cardiovascular system cause caused complications compounds concern coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 Cytokine storm drug drugs Effects Epidemics Immune cell immune cells immunomodulatory include Infection Injury MOST overproduction pandemic Potential Potential cardiotoxicity regimen regimens respiratory risk SARS-CoV-2 screened severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly subsequent Treatment virus
[DOI] 10.1007/s10557-020-07024-7 PMC 바로가기 [Article Type] Review

Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation

회복기 COVID-19 환자는 지속적인 면역 활성화로 인해 내피 기능 장애에 취약

Research Article

Published on 2021-03-232022-09-10
Journal: eLife [Category] 진단, 치료제,

[키워드] activated Activation acute infection Biomarker cardiovascular risk CD8 circulating circulating endothelial cells clinical clinical trials Complication condition convalescent correlated COVID-19 COVID-19 patient cytokine Cytokines diabetes effector cell effector T cell effector T cells elevated endothelial endothelial activation Endothelial cell endothelial cells Endothelial dysfunction event Frequency had more hallmark Health healthy controls Human hypertension immune activation immune effector cells initial mapped marker Measures non-COVID-19 patient Non-COVID-19 patients Numerous proinflammatory raising receptor recovered patients susceptible sustained T cells therapy Trial Vascular Vascular injury
[DOI] 10.7554/eLife.64909 PMC 바로가기 [Article Type] Research Article

The Weight of Obesity in Immunity from Influenza to COVID-19

인플루엔자에서 COVID-19까지의 면역에서 비만의 무게

Review

Published on 2021-03-172022-09-12
Journal: Frontiers in Cellular and Infection Microbiology [Category] SARS, 진단,

[키워드] acute respiratory syndrome addressed amplify cardiovascular disease cardiovascular risk clinical complication Comorbidity Complication complications condition coronavirus coronavirus disease COVID-19 COVID-19 hospitalization death develop diabetes Endocrine Factor favor greater Health hemodynamic instability highlight hypertension immune Immunity immunopathological immunopathology Increased individual Influenza influenza infection influenza pneumonia involved low-grade inflammation mechanism metabolic dysfunction Mortality obesity pathophysiology persistence Pneumonia poor prognosis respiratory manifestations response risk risk factor SARS-CoV-2 severe COVID-19 severe influenza susceptibility Symptom Virological weight
[DOI] 10.3389/fcimb.2021.638852 PMC 바로가기 [Article Type] Review

Sicherheitsaspekte der Therapie mit Glukokortikoiden bei rheumatoider Arthritis

Leitthema

Published on 2021-03-112024-09-04
Journal: Zeitschrift Fur Rheumatologie [Category] 대상포진,

[키워드] cardiovascular risk infections Infektionen Kardiovaskuläres Risiko Nebenwirkungen Osteoporose Osteoporosis Prognose Prognosis Side effects
[DOI] 10.1007/s00393-021-00972-x PMC 바로가기 [Article Type] Leitthema

Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?

COVID-19 및 잠재적인 심혈관 독성 치료를 위한 하이드록시클로로퀸: 영웅 또는 악당?

Review

Published on 2021-03-012022-09-11
Journal: Best practice & research. Clinical rheumatology [Category] SARS, 치료법, 치료제,

Nursing Teleconsultation for the Outpatient Management of Patients with Cardiovascular Disease during COVID-19 Pandemic

Article

Published on 2021-02-212022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS,

Luftverschmutzung und Herz-Kreislauf-Erkrankungen

Schwerpunkt

Published on 2021-01-182022-10-31
Journal: Herz [Category] COVID-19, MERS, SARS,

[키워드] Air pollutants Bildung cardiovascular risk disease Feinstaub inhalation Kardiovaskuläres Risiko KHK Luftschadstoffe Particulate matter Prävention Premature mortality prevention ROS Vorzeitige Mortalität
[DOI] 10.1007/s00059-020-05016-9 PMC 바로가기 [Article Type] Schwerpunkt

SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges

Review

Published on 2021-01-052022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] Angiotensin Converting Enzyme 2 (ACE-2) blistering cardiovascular risk causes challenge clinics contribute coronavirus disease-2019 COVID-19 COVID-19 patient COVID-19 patients creating cytokine decrease dental practice dentistry determine Diabetes Mellitus disease Effect elevated Evidence Health Healthcare professional help hygiene Infection Inflammation Inflammatory information loss of taste management metabolic disease mucosal Necrosis novel corona virus obesity opportunity oral other metabolic disease oxidative stress Patient periodontal periodontal disease Periodontitis Population prevalent problem Rash reduction respiratory routine Saliva SARS-CoV-2 SARS-COV-2 infection severity of COVID-19 Severity of infection shown susceptible Symptom symptoms of COVID-19 the disease The United States Treatment valuable resource virus with COVID-19
[DOI] 10.3390/jcm10010156 PMC 바로가기 [Article Type] Review

COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases

Review

Published on 2021-01-012023-06-16
Journal: Rheumatology International [Category] MERS,

[키워드] Antimalarials cardiovascular risk COVID-19 Hydroxychloroquine pandemic
[DOI] 10.1007/s00296-020-04759-2 PMC 바로가기 [Article Type] Review